Luxturna 5 x 10e12
As listed in the register: Luxturna 5 x 10e12, Konzentrat und Lösungsmittel zur Herstellung einer Injektionslösung
- Prescription only
- Eyes and ears
- Active substance
- Voretigenum neparvovecum
- Used in
- Eyes and ears
- Made by
- Novartis Pharma Schweiz AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Luxturna wird angewendet zur Behandlung von erwachsenen und pädiatrischen Patienten mit Sehverlust aufgrund einer erblichen Netzhautdystrophie, die auf nachgewiesenen biallelischen RPE65- Mutationen beruht und über ausreichend lebensfähige Netzhautzellen verfügen. .
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Novartis Pharma Schweiz AG |
|---|---|
| Active substance | Voretigenum neparvovecum |
| Used in | Eyes and ears |
| Classification | S01XA27 · Eyes and ears |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Luxturna 5 x 10e12, Konzentrat und Lösungsmittel zur Herstellung einer Injektionslösung |
| Packs | Beutel |
| Zulassungsnummer | 67371 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.